Polo-Like Kinase 1 Regulates Chromosomal Instability and Paclitaxel Resistance in Breast Cancer Cells

Mingji Quan; 오유미; 조승엽; 김주희; 문형곤

doi:10.4048/jbc.2022.25.e28

추천

검색

자료유형: 학술저널

저자정보: Mingji Quan (Interdisciplinary Graduate Program in Cancer Biology Seoul National University College of Medicine) 오유미 (Medical Research Center, Genomic Medicine Institute, Seoul National University College of Medicine, Seoul, Korea) 조승엽 (Medical Research Center Genomic Medicine Institute Seoul National University College of Medicine) 김주희 (Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.) 문형곤 (Cancer Research Institute, Seoul National University, Seoul, Korea.Department of Surgery, Seoul National University Hospital, Seoul, Korea.Department)

저널정보: 한국유방암학회 Journal of Breast Cancer Journal of Breast Cancer Vol.25 No.3

발행연도: 2022.6

수록면: 178 - 192 (15page)

DOI: 10.4048/jbc.2022.25.e28

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Purpose: Chromosomal instability (CIN) contributes to intercellular genetic heterogeneity and has been implicated in paclitaxel (PTX) resistance in breast cancer. In this study, we explored polo-like kinase 1 (PLK1) as an important regulator of mitotic integrity and as a useful predictive biomarker for PTX resistance in breast cancer. Methods: We performed PTX resistance screening using the human kinome CRISPR/Cas9 library in breast cancer cells. In vitro cell proliferation and apoptosis assays and in vivo xenograft experiments were performed to determine the effects of PLK1 on breast cancer cells. Immunofluorescence microscopy was used to measure the degree of multipolar cell division. Results: Kinome-wide CRISPR/Cas9 screening identified various kinases involved in PTX resistance in breast cancer cells; among these, PLK1 was chosen for further experiments. PLK1 knockdown inhibited the proliferation of MDA-MB-231 and MDA-MB-468 cells in vitro and in vivo. Moreover, PLK1 silencing sensitized breast cancer cells and mouse xenograft tumor models to PTX cytotoxicity. Silencing of PLK1 induced the formation of multipolar spindles and increased the percentage of multipolar cells. In addition, PLK1 silencing resulted in the downregulation of BubR1 and Mad2 in breast cancer cells. Furthermore, PLK1 upregulation in primary breast cancer was associated with decreased overall patient survival based on the analysis of The Cancer Genome Atlas and Molecular Taxonomy of Breast Cancer International Consortium databases. Conclusion: PLK1 plays an important role in PTX resistance by regulating CIN in breast cancer cells. Targeting PLK1 may be an effective treatment strategy for PTX-resistant breast cancers.

#Breast Neoplasms #CRISPR-Cas Systems #Paclitaxel #Polo-Like Kinase 1 #Spindle Poles

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

Mingji Quan

소속기관 Interdisciplinary Graduate Program in Cancer Biology Seoul National University College of Medicine